Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001305860 | SCV001495208 | uncertain significance | MHC class II deficiency | 2022-06-20 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1008509). This variant has not been reported in the literature in individuals affected with RFX5-related conditions. This variant is present in population databases (rs773920954, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 262 of the RFX5 protein (p.Arg262Trp). |
Ambry Genetics | RCV004036372 | SCV004937779 | uncertain significance | not specified | 2023-09-21 | criteria provided, single submitter | clinical testing | The c.784C>T (p.R262W) alteration is located in exon 10 (coding exon 8) of the RFX5 gene. This alteration results from a C to T substitution at nucleotide position 784, causing the arginine (R) at amino acid position 262 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |